Faculty Biography

Stephen M. Koch, M.D.

Associate Professor

Back

Education and Post-Graduate Training

M.D., University of Arizona College of Medicine, Tucson, Arizona

Internal Medicine Internship, Maricopa Medical Center, Phoenix, Arizona

Internal Medicine Residency, Maricopa Medical Center, Phoenix, Arizona

Critical Care Medicine Fellowship, Baylor College of Medicine, Houston, Texas

Certificate of Business Administration, Executive Healthcare Training Institute, University of Houston - Clear Lake, Clear Lake, Texas

Professional Experience

Associate Professor, Department of Anesthesiology, The University of Texas Medical School at Houston, Houston, Texas

Assistant Professor, Department of Anesthesiology, The University of Texas Medical School at Houston, Houston, Texas

Certification

Diplomat of National Board of Medical Examiners

American Board of Internal Medicine: Internal Medicine

American Board of Internal Medicine: Critical Care

Professional Organizations

Harris County Medical Society

Texas Medical Association

Greater Houston Society of Critical Care, Charter Member

Harris County Medical Society Council of Hospital Chiefs of Staff

Society of Critical Care Medicine

American College of Physicians

Undersea and Hyperbaric Medical Society

American College of Chest Physicians

American Thoracic SocietyIsoneurem: International Society for Neuroemergencies - Founding Member

Awards

1976 National Mortar Board Society

1977 Magna Cum Laude, Occidental College

1977 Arizona Medical Association Scholarship

1986, 1989 Maricopa Medical Center Attending of the Year

1989 Maricopa Medical Center Department of Internal Medicine Special Recognition Award

1993-1995 The University of Texas Medical School at Houston Dean's Teaching Excellence Award, Department of Anesthesiology

1994 Fellow, American College of Chest Physicians

1995 Teaching Attending of the Year, Department of Anesthesiology

1997 Fellow, American College of Critical Care Medicine

1999-2000 The University of Texas Medical School at Houston Dean's Teaching Excellence Award, Department of Anesthesiology

2000 Fellow, American College of Physicians

Research Projects

• 1/03 to Present; Co-Investigator: A Phase II Clinical Trial of a Timing/Schedule Optimized Combined-Modality Regimen: Cisplatin + Metronomic Low-Dose Interferon-A (IFN-A) Followed by Gemcitabine Hcl (Gemzar) In Combination With Mild, Fever-Range Whole-Body Hyperthermia (FR-WBH) in Patients with Advanced, Inoperable Pancreatic Cancer (HSC-MS-02-117)
• 4/5/05 to Present; Co-Investigator: A Randomized Phase II Clinical Trial of Optimally Scheduled Chemo-Biotherapy With or Without Fever-Range Whole-Body Hyperthermia (FR-WB-TT) in Patients with Locally Invasive Pancreas Cancer (HSC-MS-05-0022)
• 4/5/05 to Present; Co-Investigator: A Phase II Clinical Trial of Cisplatin (Platinol) Followed by Gemcitabine HCl (Gemzar) in Combination with Mild, Fever-Range, Whole Body Thermal-Therapy (FR-WB-TT) of 40 C (104 F) in Patients with Advanced Malignancies (HSC-MS-04-259)

Selected Publications

• Bull JM, Koch SM, Scott GL, Strebel FR, Nagle VL, Berry JM, Ahn CW. Fever-range whole-body thermal-therapy combined with cisplatin, gemcitabine, and daily interferon-alpha. A description of a phase I-II protocol. Int J Hyperthermia 4:1-14, 2008
• Bull JM, Scott GL, Figueroa G, Tompte S, Danczak T, Strebel FR, Oliver DH, Redwine MD, Koch SM: An update of a phase II clinical trial using fever-range whole-body thermal therapy (FR-WB-TT) + cisplatin (CIS) + gemcitabine (GEM) + metronomic, low-dose interferon-alpha (FIN-alpha) for inoperable or metastatic pancreatic cancer. In: Proceedings of the 25th National Meeting of the Society for Thermal Medicine (STM) Annual Meeting and the World Conference of Interventional Oncology, Washington, DC, May 14-17, 2007.
• Schmitz, BU, Koch SM, Parks DH. Airway Management in Burn Patients. Benumof’s Airway Management 2nd edition. In: CA Hagberg (ed). Mosby, Inc., St. Louis. Chapter 41: 997-1008, 2007.
• Bull JMC, Scott G, Strebel FR, Oliver DH, Redwine M, Koch SM: An update of a phase II clinical trial using fever-range whole-body thermal-therapy (FR-WB-TT) + cisplatin (CIS) + gemcitabine (GEM) + metronomic, low-dose interferon-alpha (IFN-alpha) for inoperable or metastatic pancreas cancer. Plenary session. In: Proceedings of the 24th National Meeting of the Society for Thermal Medicine (STM) Annual Meeting in Bethesda, MD, March 6-9, 2006.
• Herlihy JP, Koch SM, Jackson R, Nora H: Course of weaning from prolonged mechanical ventilation after cardiac surgery. Tex Heart Inst J 33:122-129, 2006.
• Kratschmer R, Pivalizza EG, Koch SM, Wainright DJ, Freet D, Parks DH: Coagulation changes during initial resuscitation in severely burned patients. Anesth Analg 102:S82, 2006.
• Bull JMC, Scott GL, Oliver DH, Raval B, Koch SM: A new phase II clinical trial for locally advanced and inoperable pancreas cancer using fever-range whole-body hyperthermia (FR-WB-TT) + cisplatin (CIS) + gemcitabine (GEM) + metronomic low-dose interferon-alpha (IFN-alpha). In: Proceedings of the 23rd National Meeting of the Society of Thermal Medicine (formerly North American Hyperthermia Society) in Bethesda, MD, April 2005.
• Warters RD, Katz J, Szmuk P, Luehr SL, Pivalizza EG, Koch SM, Price M, Ezri T: Development criteria for future academic leaders of Anesthesiology: Have they changed? Anesth Analg 95:1019-1023, 2002.
• Koch SM, Warters RD, Mehlhorn U: The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care 17: 203-205, 2002.
  

Location & Contact

6431 Fannin Street,
MSB 5.020
Houston, Texas 77030

713.500.6200

713.500.6208 fax

Faculty Biography

• Stephen M. Koch, M.D.
  Associate Professor
• Department of Anesthesiology
  The University of Texas Medical School at Houston
• University of Texas-Houston Medical School
  6431 Fannin Street, MSB-5.174
  Houston, Texas 77030
• phone: (713) 500-6243
  e-mail: Stephen.M.Koch@uth.tmc.edu